Company Valuation: Conavi Medical Corp.

Data adjusted to current consolidation scope
Fiscal Period: September 2025
Market Cap 1 51.42
Change -
Enterprise Value (EV) 1 65.49
Change -
P/E -1.88x
PBR -2.85x
PEG 0x
Capitalization / Revenue 5.64x
EV / Revenue 7.18x
EV / EBITDA -4.56x
EV / EBIT -4.41x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 -0.3567
Distribution rate -
Net sales 1 9.122
EBITDA 1 -14.37
EBIT 1 -14.85
Net income 1 -20.52
Net Debt 1 14.06
Reference price 2 0.6700
Nbr of stocks (in thousands) 76,750
Announcement Date 12/29/25
1CAD in Million2CAD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 12.15M
34.61x6.04x23.12x0.27% 258B
39.39x6.96x22.02x0.62% 163B
45.71x12.3x27.14x-.--% 151B
16.59x3.33x10.84x-.--% 63.97B
35.43x6.97x22.13x-.--% 50.78B
20.05x2.41x12.18x2.52% 50.94B
34.21x6.76x22.95x0.59% 49.49B
47.93x11.82x26.06x-.--% 50.68B
77.76x7.4x22.54x-.--% 43.64B
Average 39.07x 7.11x 21.00x 0.44% 88.09B
Weighted average by Cap. 38.17x 7.37x 22.16x 0.37%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Conavi Medical Corp.

Historical PBR trend

Valuation ratios - PBR - Conavi Medical Corp.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Conavi Medical Corp.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Conavi Medical Corp.

  1. Stock Market
  2. Stocks
  3. CNVI Stock
  4. Valuation Conavi Medical Corp.